Evidence map›Paper›PMID 40242793›Full record

ArticleIBRO neuroscience reports2025

Parvalbumin-positive primary afferent projections to motoneurons increase after complete spinal transection in neonatal and juvenile rats.

Masahito Takiguchi, Ryutaro Matsuyama, Satoru Shinoda, Kengo Funakoshi

Abstract read
In one paragraph

Article in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masahito TakiguchiDepartment of Neuroanatomy, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama, Japan.
Ryutaro MatsuyamaDepartment of Neuroanatomy, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama, Japan.
Satoru ShinodaDepartment of Biostatics, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama, Japan.
Kengo FunakoshiDepartment of Neuroanatomy, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hindlimb locomotor activity spontaneously recovers after complete spinal cord transection (CST) in neonatal rats, but not in juvenile rats. A previous study in neonatal rats that underwent CST at the thoracic level demonstrated that primary afferent projections increase in the ventral horn and intermediate zone at the lumbar level. It remains unclear whether primary afferent terminals of motoneurons increase and whether primary afferent projections to the spinal cord are altered after CST in juvenile rats. Here, we used biotinylated dextran amine as a tracer to demonstrate that primary afferent projections to the ventral horn and intermediate zone were significantly increased in rats that underwent CST in the juvenile period compared to intact rats of the same age. We then examined Ⅰa afferents using immunohistochemistry for parvalbumin. Our findings revealed an increase in parvalbumin-immunoreactive terminals on motoneurons in both neonatal and juvenile rats after CST compared to intact rats of the same age. These results suggest that proprioceptive afferent terminals on motoneurons are increased after CST in both neonatal and juvenile rats. In neonatal rats, this increase might contribute to the spontaneous recovery of hindlimb motor activity after CST, whereas in juvenile rats, the increase in proprioceptive afferent terminals on motoneurons does not contribute to recovery following CST.

Indexed as

JuvenileMotoneuronsNeonateParvalbuminPrimary afferentsSpinal cord injury

Identifiers

PMID40242793
PMCPMC12002873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.